Show simple item record

dc.contributor.authorCagney, Daniel N
dc.contributor.authorDunne, Mary
dc.contributor.authorO'Shea, Carmel
dc.contributor.authorFinn, Marie
dc.contributor.authorNoone, Emma
dc.contributor.authorSheehan, Martina
dc.contributor.authorMcDonagh, Lesley
dc.contributor.authorO'Sullivan, Lydia
dc.contributor.authorThirion, Pierre
dc.contributor.authorArmstrong, John
dc.date.accessioned2017-08-11T11:53:23Z
dc.date.available2017-08-11T11:53:23Z
dc.date.issued2017-08-01
dc.identifier.citationHeterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy. 2017, 17 (1):60 BMC Urolen
dc.identifier.issn1471-2490
dc.identifier.pmid28764689
dc.identifier.doi10.1186/s12894-017-0250-2
dc.identifier.urihttp://hdl.handle.net/10147/622506
dc.description.abstractOur aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT).
dc.language.isoenen
dc.rightsArchived with thanks to BMC urologyen
dc.subjectPROSTATE CANCERen
dc.subjectRADIOTHERAPYen
dc.titleHeterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy.en
dc.typeArticleen
dc.identifier.journalBMC urologyen
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
refterms.dateFOA2018-08-27T22:45:42Z
html.description.abstractOur aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT).


Files in this item

Thumbnail
Name:
bmc uROLOGY.pdf
Size:
681.0Kb
Format:
PDF
Description:
Article

This item appears in the following Collection(s)

Show simple item record